Published 16 February 2009, doi:10.1136/bmj.a3065
Cite this as: BMJ 2009;338:a3065

Editorials

HDL cholesterol and cardiovascular risk

Treatments can increase HDL cholesterol, but do not independently reduce risk

The first 150 words of the full text of this article appear below.

History tends to repeat itself, in the medical sciences as in other domains. In the linked systematic review (doi:10.1136/bmj.b92), Briel and colleagues put high density lipoprotein (HDL) cholesterol into perspective as a marker of risk, and their findings evoke memories of other risk markers.1 Like HDL cholesterol, premature ventricular contractions are a validated risk marker for cardiovascular disease. Such contractions indicate an increased risk for adverse cardiovascular outcomes in the general population and in patients presenting with cardiovascular disease.2 3 Yet specific treatments that eliminate these contractions do not decrease the risk for adverse outcomes and can even increase risk.4 Thus, modifying the known marker of increased risk does not necessarily modify the risk itself.

Briel and colleagues demonstrate this phenomenon for HDL cholesterol in a meta-regression study of 108 clinical trials that assessed more than 300 000 patients and several lipid modifying treatments.1 They found that although some . . . [Full text of this article]

William A Ghali, professor1, Nicolas Rodondi, senior lecturer2

1 Departments of Medicine and Community Health Sciences, Faculty of Medicine, University of Calgary, Calgary, AB, Canada, T2N 4N1, 2 Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, CH1011, Switzerland

wghali@ucalgary.ca


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
Matthias Briel, Ignacio Ferreira-Gonzalez, John J You, Paul J Karanicolas, Elie A Akl, Ping Wu, Boris Blechacz, Dirk Bassler, Xinge Wei, Asheer Sharman, Irene Whitt, Suzana Alves da Silva, Zahira Khalid, Alain J Nordmann, Qi Zhou, Stephen D Walter, Noah Vale, Neera Bhatnagar, Christopher O’Regan, Edward J Mills, Heiner C Bucher, Victor M Montori, and Gordon H Guyatt
BMJ 2009 338: b92. [Abstract] [Full Text] [PDF]

Adherence to Mediterranean diet and health status: meta-analysis
Francesco Sofi, Francesca Cesari, Rosanna Abbate, Gian Franco Gensini, and Alessandro Casini
BMJ 2008 337: a1344. [Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Treating disease markers
Andrew S Thornton
bmj.com, 3 Mar 2009 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ